HeartBeam (BEAT)
(Delayed Data from NSDQ)
$2.36 USD
-0.05 (-2.07%)
Updated Nov 12, 2024 04:00 PM ET
After-Market: $2.35 -0.01 (-0.42%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMWe use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$2.36 USD
-0.05 (-2.07%)
Updated Nov 12, 2024 04:00 PM ET
After-Market: $2.35 -0.01 (-0.42%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGM
Zacks News
The Zacks Analyst Blog Highlights: Banner, Amazon.com, BJ's, athenahealth and BioTelemetry
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Banner, Amazon.com, BJ's, athenahealth and BioTelemetry
Bull Run Set to Become the Longest in History: 5 Winners
by Tirthankar Chakraborty
The current bull market in U.S. stocks is about to become the longest on record, and optimistic analysts are predicting that it has miles to go before it rests.
Should First Trust Small Cap Growth AlphaDEX Fund (FYC) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for FYC
Top Ranked Momentum Stocks to Buy for August 7th
by Zacks Equity Research
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, August 7th:
Options Traders Expect Huge Moves in BioTelemetry (BEAT) Stock
by Zacks Equity Research
BioTelemetry (BEAT) needs investors to pay close attention to the stock based on moves in the options market lately.
Zacks.com featured highlights include: BioTelemetry, Fair Isaac, Comerica and Blue Hills
by Zacks Equity Research
Zacks.com featured highlights include: BioTelemetry, Fair Isaac, Comerica and Blue Hills
4 Top Stocks to Buy on Blockbuster Earnings Growth
by Tirthankar Chakraborty
We shortlist four solid stocks that have striking earnings growth and positive estimate revisions.
Top Ranked Momentum Stocks to Buy for July 31st
by Zacks Equity Research
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, July 31st:
Elevate Credit (ELVT) and BioTelemetry (BEAT) Are Aggressive Growth Stocks
by Brian Bolan
A look at two stocks for your aggressive growth stock radar.
NovoCure (NVCR) Catches Eye: Stock Jumps 7.4%
by Zacks Equity Research
NovoCure (NVCR) saw a big move last session, as its shares jumped more than 7% on the day, amid huge volumes.
Biocept, Inc. (BIOC) Soars: Stock Adds 9.8% in Session
by Zacks Equity Research
Biocept (BIOC) was a big mover last session, as the company saw its shares rise more than 9% on Friday amid huge volumes.
Natera (NTRA) Catches Eye: Stock Jumps 6.3%
by Zacks Equity Research
Natera (NTRA) shares rose more than 6% in the last trading session, amid huge volumes.
BioTelemetry (BEAT) Beats Q4 Earnings and Revenue Estimates
by Zacks Equity Research
BioTelemetry (BEAT) sees strong Q4 results, courtesy of solid acquisitions and promising performance by the MCT platform.
BioTelemetry's (BEAT) Telcare Unit Collaborates With Onduo
by Zacks Equity Research
BioTelemetry (BEAT) progresses with deals to strengthen hold in the high-potential diabetes care market.
BioTelemetry Ties Up With Apple, Grows in Cardiac Monitoring
by Zacks Equity Research
BioTelemetry (BEAT) is consistently trying to improve its position in the cardiac monitoring and diagnostic services space.
BioTelemetry (BEAT) Q3 Earnings Miss, Revenues Meet Estimates
by Zacks Equity Research
A decline in gross and operating margin was a major drag for BioTelemetry (BEAT) in the third quarter.
BioTelemetry, Royal Gold, Microsoft and Amazon highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
BioTelemetry, Royal Gold, Microsoft and Amazon highlighted as Zacks Bull and Bear of the Day
Bull of the Day: BioTelemetry (BEAT)
by Kevin Cook
This small veteran in the "connected health" space doesn't need to beat Apple to win
PAREXEL's Acquisition by Pamplona Approved by Shareholders
by Zacks Equity Research
The long-awaited PAREXEL (PRXL) acquisition by Pamplona Capital Management finally receives shareholders' approval. Moreover, the company plans to go private post-acquisition.
Here's Why Mazor Robotics (MZOR) Stock Is Worth a Bet Now
by Zacks Equity Research
The market is upbeat about Mazor Robotics' (MZOR) recent CE Mark approval for Mazor X Surgical Assurance platform.
Here's Why You Should Invest in Orthofix International Now
by Zacks Equity Research
Orthofix (OFIX) rides high on strength in Biologics and Spine Fixation.
Zacks.com featured highlights include JA Solar Holdings, BioTelemetry, Arista Networks, Owens Corning and Aaron's
by Zacks Equity Research
Zacks.com featured highlights include JA Solar Holdings, BioTelemetry, Arista Networks, Owens Corning and Aaron's
Here's Why You Should Bet on BioTelemetry (BEAT) Stock Now
by Zacks Equity Research
BioTelemetry's (BEAT) consistent efforts in product innovation through research and development buoy optimism. Also, the recent acquisition instills confidence in investors.
5 Momentum Stocks Powered by Driehaus Strategy
by Zacks Equity Research
One of the most widely used investment approaches for those interested in momentum stocks is the Driehaus strategy
Can BioTelemetry (BEAT) Run Higher on Strong Earnings Estimate Revisions?
by Zacks Equity Research
BioTelemetry (BEAT) is seeing solid earnings estimate revisions, and the stock is showing decent short-term momentum as well.